NCT06459843 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Rodrigues A, Munoz Castro G, Jacome C, Langer D, Parry SM, Burtin C
Current developments and future directions in respiratory physiotherapy. Eur Respir Rev. 2020 Dec 15;29(158):200264. doi: 10.1183/16000617.0264-2020. Print 2020 Dec 31.
Thurlbeck WM, Muller NL
Emphysema: definition, imaging, and quantification. AJR Am J Roentgenol. 1994 Nov;163(5):1017-25. doi: 10.2214/ajr.163.5.7976869.

Combined Effects Of of Pursed Lip Breathing and Coordinated Breathing During Aerobic Exercise on Aerobic Capacity, Dyspnea and Anxiety Level in Adult Patients With COPD

Details for clinical trial NCT06459843

Clinical trial NCT06459843 - References